Find more items about these cancer types:

Breast

San Antonio Breast Cancer Symposium 2008

Dec 10-14 2008 San Antonio, TX

This year's symposium is the first to be presented by the CTRC, AACR, and the Baylor College of Medicine. The driving force behind the new collaboration is the shared mission of the organizations to advance progress against breast cancer. By combining their respective strengths, the 2008 San Antonio Breast Cancer Symposium now encompasses the full spectrum of breast cancer research and facilitate the rapid transition of new knowledge into improved care for breast cancer patients.

Commentary

SABCS 2008: Shaping the Standard of Care for 2009

2009 Jan 6, Lee Schwartzberg, MD, Editor-in-Chief

News

Pinning Down Risks and Benefits of G-CSF–Supported Chemotherapy

Elsevier Global Medical News. 2009 Jan 30, B Jancin

All-Oral Combo Chemotherapy Attractive in Metastatic Breast Cancer

Elsevier Global Medical News. 2009 Jan 22, B Jancin

Novel Protector Against Breast Cancer: Lobular Involution

Elsevier Global Medical News. 2009 Jan 21, B Jancin

Tamoxifen, But Not Exemestane, Worsens Cognition

Elsevier Global Medical News. 2009 Jan 21, K Wachter

What Patients Are Reading

Taking Menopausal Hormones for 5 Years Doubles Breast Ca Risk

As Reported by The Associated Press. 2008 Dec 13

Small Breast Tumors With High HER2 Levels May Recur

As Reported by The Associated Press. 2008 Dec 12

Video

Acupuncture in Breast Cancer

Elsevier Global Medical News. 2008 Dec 12, B Jancin
OncologySTAT Video Network

Adjuvant AIs vs Tamoxifen

Elsevier Global Medical News. 2008 Dec 11, K Wachter
OncologySTAT Video Network

Biomarkers in Breast Cancer

Elsevier Global Medical News. 2008 Dec 12, K Wachter
OncologySTAT Video Network

TEAM Trial Results: Critical Analysis

Elsevier Global Medical News. 2008 Dec 12, K Wachter
OncologySTAT Video Network

TEAM Trial: Exemestane vs Tamoxifen

Elsevier Global Medical News. 2008 Dec 11, K Wachter
OncologySTAT Video Network

Community CommentsTotal comments to date:

Editors' Choice

Cetuximab and First-Line Taxane/Carboplatin in Advanced NSCLC

Cancer Types Spotlight

  • Bladder
  • Bone
  • Breast
  • Breast (ER Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • HIV-Related Cancers
  • Bladder
  • Bone
  • Breast
  • Breast (ER Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • HIV-Related Cancers
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin (Melanoma)
  • Skin (Non-Melanoma)
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration